[APVO] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[APVO] Aptevo Therapeutics Inc.
Announcement Date
05-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 6.80%
YoY- -119.45%
Quarter Report
APVO's Result
APVO's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 902 -3,114 3,665 2,373 9,031 6,346 2,818 -17.28%
PBT -6,196 -5,163 -6,597 -7,171 -8,174 -14,024 -17,409 -15.81%
Tax -293 -35,515 626 13,055 999 104 -7,714 -42.00%
NP -5,903 30,352 -6,272 -7,053 -8,174 -14,128 -9,760 -8.03%
Tax Rate - - - - - - - -
Total Cost 6,805 -33,466 9,937 9,426 17,205 20,474 12,578 -9.72%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -654.43 -974.69 -171.13 -297.22 -90.51 -222.63 -346.34 11.18%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -11.85 251.60 -56.32 -80.32 -111.09 -383.27 -276.12 -40.81%
EPS Diluted -11.85 249.74 -56.32 -80.32 -111.09 -383.27 -274.20 -40.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.